BRIAN P. MCKEON - 05 Aug 2022 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Executive VP & CFO
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Brian P. McKeon
Issuer symbol
IDXX
Transactions as of
05 Aug 2022
Net transactions value
-$36,700
Form type
4
Filing time
08 Aug 2022, 17:01:21 UTC
Previous filing
08 Jul 2022
Next filing
10 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +192 +0.68% $0.000000 28,366 05 Aug 2022 Direct F1
transaction IDXX Common Stock Tax liability $36,700 -90 -0.32% $407.78 28,276 05 Aug 2022 Direct
holding IDXX Common Stock 18,050 05 Aug 2022 by Estony McKeon Family, LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Restricted Stock Unit Options Exercise -192 -4% 4,593 05 Aug 2022 Common Stock 192 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes a total of 20 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2022 and June 30, 2022.
F2 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning August 5, 2020.
F3 Not applicable.